The RWD & RWE Podcast

Ep 124 [24 January 2024]: Brigham Hyde PhD – Closing the RWE gap in medicine with real-world patient data

Ep 124 [24 January 2024]: Conversation with Brigham Hyde PhD, CEO at Atropos Health – We discussed closing the evidence gap in medicine with real world patient data. It was an interesting conversation on the importance of democratizing access to data and how accelerating the generation of actionable evidence from a federated network of data will improve healthcare for everyone.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 123 [17 January 2024]: Alicia Bertone DVM PhD – One Medicine: Unlock RWD/E from our animal companions

Ep 123 [17 January 2024]: Conversation with Alicia Bertone DVM PhD, an equine orthopedic surgeon, CSO at Equine Performance Labs, industry advisor and endowed Chair of "One medicine" research, with past roles as a University Dean, Provost and Vice Chancellor – We discussed innovative medicines for humans that already exist for animals and focus on the overlap of animal & human health, centralization and personalization of health records, clinical trials that employ RWD, as well as environmental RWD & RWE for various diseases and behavioral risks.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 122 [10 January 2024]: MaryAnne Rizk PhD – The impact of RWD with Digital Health Technology adoption

Ep 122 [10 January 2024]: Conversation with MaryAnne Rizk PhD (“Mar”), from Rizk Management Advisors, for a special “Live from JPM” episode. Building on Mar’s vast industry experience, she currently advises clients on the creation of strategic partnerships across the life science ecosystem. Mar will discuss the profound impact of RWD and the surge in Digital Health Technology adoptions. In this episode, we’ll unpack the significance of RWD within these clinical trials, exploring RWD’s pivotal role amidst the rise of digital health solutions. Additionally, we will unravel some of the latest insights from the FDA’s groundbreaking guidance on Digital Health Technology (December 2023), specifically its implications for remote care and impact on clinical investigation.

Ep 121 [03 January 2024]: Janak Joshi – Its time to get real about real world evidence

Ep 121 [03 January 2024]: Conversation with Janak Joshi, former CTO of LifeImage and currently the Chief Digital Officer for State of Massachusetts – We discussed Real World Evidence, specifically, what has worked and where are we heading into the future to address challenges with RWE programs in pharma research. We'll focus on future considerations for RWE and Fully Consented Real World Networks, the potential value of AI, exploring ways to mitigate the burden of RWD accessibility and acceleration of time cycles with improved diversity and retention.

Ep 120 [13 December 2023]: Dan Poscover MBA and Dr. Patrick Hanson – Hola, Ciao, Bon Jour - RWE network building in Europe

Ep 120 [13 December 2023]: Conversation with Dan Poscover MBA, CEO and Co-Founder of Graticule, and Dr. Patrick Hanson, Chief Alliance Officer of Graticule – We discussed the EU lessons learned while establishing am RWE network in Italy, France, and Spain within the context of evidence readiness that aims to meet global needs for studies on immunocompromised patients.

Ep 119 [06 December 2023]: Kathy Belk – The ‘other’ under-represented population: Rural RWD for RWE

Ep 119 [06 December 2023]: Conversation with Kathy Belk, Sr Dir Analytics & Chief Data Scientist for Spacelabs, Co-founder of Elev8Evidence and Founder of Health Clarity Solutions – A great conversation that explored the complexities of healthcare challenges in the rural population, including social drivers of health, access to care, and the often-overlooked nuances impacting rural communities. We discussed how real-world data and data-driven solutions can help provide actionable insight to tackle these challenges head-on.

Ep 118 [29 November 2023]: Mark Shapiro PhD MS MBA – RWD from EHR: Challenges and Opportunities

Ep 118 [29 November 2023]: Conversation with Mark Shapiro PhD MS MBA, Chief Operating Officer (COO) at xCures – We discussed how RWD can be created from electronic health records; in particular, our experience with collection from disparate EHR sources to produce a more complete patient journey, with some of the challenges and risks using disparate EHR sources and to talk about data normalization, privacy concerns and how EHR-derived RWD can benefit patient care and medical research.

Ep 117 [15 November 2023]: Georges De Feu & Shahbaz Pervaiz – Unlock European RWE

Ep 117 [15 November 2023]: Conversation with Georges De Feu, CEO and co-founder of LynxCare – a European RWD provider is joined by his RWE Services Director – Shahbaz Pervaiz – We discussed the need for NLP-AI to unlock European unstructured data and the enablers for federated networks of hospital.

Ep 116 [08 November 2023]: Canter Martin MBA – Selecting the Right RWE/RWD Partner

Ep 116 [08 November 2023]: Conversation with Canter Martin MBA, Executive Leader in Life Science Value & Access and Co-Founder of Elev8Evidence – We discussed the importance of strategic partnerships in the effective use of RWD and generating meaningful RWE -- Best practices in selecting the right partner!

Ep 115 [01 November 2023]: Carla DeMuro MS – RWD - Are we measuring the right thing?

Ep 115 [01 November 2023]: Conversation with Carla DeMuro MS, Vice President, Patient-Centered Outcomes Assessment at RTI Health Solutions – We discussed the use of PROs in real-world evidence generation. Are we measuring the right thing?